Lansoprazole
NDC 0093-7351, Lansoprazole, capsule, delayed release, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-7351
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077255
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-7351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANSOPRAZOLE30 mg/1
Pharmacologic classes
Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-7351-56 | 00093735156 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0093-7351-56) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/427cf924-be17-47dc-8f77-115fa2f3fe17NADAC price for package 00093735156
GET /v1/drugs/nadac/00093735156
Use it
Look up 0093-7351 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-7351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-7351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.